These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22185371)

  • 1. Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide.
    Yan T; Skaftnesmo KO; Leiss L; Sleire L; Wang J; Li X; Enger PØ
    BMC Cancer; 2011 Dec; 11():524. PubMed ID: 22185371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells.
    Johannessen TC; Prestegarden L; Grudic A; Hegi ME; Tysnes BB; Bjerkvig R
    Neuro Oncol; 2013 Mar; 15(3):269-78. PubMed ID: 23258843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors.
    Wang Z; Yang J; Xu G; Wang W; Liu C; Yang H; Yu Z; Lei Q; Xiao L; Xiong J; Zeng L; Xiang J; Ma J; Li G; Wu M
    Oncotarget; 2015 Feb; 6(5):3147-64. PubMed ID: 25605243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein alterations associated with temozolomide resistance in subclones of human glioblastoma cell lines.
    Sun S; Wong TS; Zhang XQ; Pu JK; Lee NP; Day PJ; Ng GK; Lui WM; Leung GK
    J Neurooncol; 2012 Mar; 107(1):89-100. PubMed ID: 21979894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperoxia resensitizes chemoresistant glioblastoma cells to temozolomide through unfolded protein response.
    Lee D; Sun S; Ho AS; Kiang KM; Zhang XQ; Xu FF; Leung GK
    Anticancer Res; 2014 Jun; 34(6):2957-66. PubMed ID: 24922660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PI3K inhibitor GDC-0941 enhances radiosensitization and reduces chemoresistance to temozolomide in GBM cell lines.
    Shi F; Guo H; Zhang R; Liu H; Wu L; Wu Q; Liu J; Liu T; Zhang Q
    Neuroscience; 2017 Mar; 346():298-308. PubMed ID: 28147244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe.
    Pérès EA; Gérault AN; Valable S; Roussel S; Toutain J; Divoux D; Guillamo JS; Sanson M; Bernaudin M; Petit E
    Oncotarget; 2015 Feb; 6(4):2101-19. PubMed ID: 25544764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FERMT3 contributes to glioblastoma cell proliferation and chemoresistance to temozolomide through integrin mediated Wnt signaling.
    Lu C; Cui C; Liu B; Zou S; Song H; Tian H; Zhao J; Li Y
    Neurosci Lett; 2017 Sep; 657():77-83. PubMed ID: 28778805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD74 in high grade gliomas: a potential role in temozolomide resistance.
    Kitange GJ; Carlson BL; Schroeder MA; Decker PA; Morlan BW; Wu W; Ballman KV; Giannini C; Sarkaria JN
    J Neurooncol; 2010 Nov; 100(2):177-86. PubMed ID: 20443131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic TRADD confers a worse prognosis in glioblastoma.
    Chakraborty S; Li L; Tang H; Xie Y; Puliyappadamba VT; Raisanen J; Burma S; Boothman DA; Cochran B; Wu J; Habib AA
    Neoplasia; 2013 Aug; 15(8):888-97. PubMed ID: 23908590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldehyde dehydrogenase 1A1--a new mediator of resistance to temozolomide in glioblastoma.
    Schäfer A; Teufel J; Ringel F; Bettstetter M; Hoepner I; Rasper M; Gempt J; Koeritzer J; Schmidt-Graf F; Meyer B; Beier CP; Schlegel J
    Neuro Oncol; 2012 Dec; 14(12):1452-64. PubMed ID: 23132408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway.
    Tabouret E; Tchoghandjian A; Denicolai E; Delfino C; Metellus P; Graillon T; Boucard C; Nanni I; Padovani L; Ouafik L; Figarella-Branger D; Chinot O
    Oncotarget; 2015 May; 6(13):11664-75. PubMed ID: 25860928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FoxM1 inhibition sensitizes resistant glioblastoma cells to temozolomide by downregulating the expression of DNA-repair gene Rad51.
    Zhang N; Wu X; Yang L; Xiao F; Zhang H; Zhou A; Huang Z; Huang S
    Clin Cancer Res; 2012 Nov; 18(21):5961-71. PubMed ID: 22977194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of TRAP1 sensitizes glioblastoma cells to temozolomide chemotherapy through regulating metabolic reprogramming.
    Wu J; Liu Y; Cho K; Dong X; Teng L; Han D; Liu H; Chen X; Chen X; Hou X; Peng F; Bi Y; Shen C; Zhao S
    Neuroreport; 2016 Feb; 27(3):136-44. PubMed ID: 26716385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of expression and prognostic significance of vimentin and the response to temozolomide in glioma patients.
    Lin L; Wang G; Ming J; Meng X; Han B; Sun B; Cai J; Jiang C
    Tumour Biol; 2016 Nov; 37(11):15333-15339. PubMed ID: 27704357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of EGFRvIII in glioblastoma: prognostic significance revisited.
    Montano N; Cenci T; Martini M; D'Alessandris QG; Pelacchi F; Ricci-Vitiani L; Maira G; De Maria R; Larocca LM; Pallini R
    Neoplasia; 2011 Dec; 13(12):1113-21. PubMed ID: 22241957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma.
    Kohsaka S; Takahashi K; Wang L; Tanino M; Kimura T; Nishihara H; Tanaka S
    Cancer Lett; 2013 Apr; 331(1):68-75. PubMed ID: 23246370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of Nrf2 enhances autophagy induced by temozolomide in U251 human glioma cell line.
    Zhou Y; Wang HD; Zhu L; Cong ZX; Li N; Ji XJ; Pan H; Wang JW; Li WC
    Oncol Rep; 2013 Jan; 29(1):394-400. PubMed ID: 23128449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of histone deacetylase 2 suppresses malignancy for proliferation, migration, and invasion of glioblastoma cells and enhances temozolomide sensitivity.
    Zhang Z; Wang Y; Chen J; Tan Q; Xie C; Li C; Zhan W; Wang M
    Cancer Chemother Pharmacol; 2016 Dec; 78(6):1289-1296. PubMed ID: 27832326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of BRCA1-BRCA2-containing complex subunit 3 sensitizes glioma cells to temozolomide.
    Chai KM; Wang CY; Liaw HJ; Fang KM; Yang CS; Tzeng SF
    Oncotarget; 2014 Nov; 5(21):10901-15. PubMed ID: 25337721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.